|
|
|
|
Biotherapeutic peptides represent a promising class of therapeutics that offer significant advantages over traditional small-molecule drugs, particularly in terms of safety and efficacy. Learn why rigorous impurity profiling is vital to ensure product quality and regulatory compliance.
|
|
|
|
|
GLP-1 receptor agonists are transforming the landscape of modern therapeutics, extending far beyond their original role in managing type 2 diabetes. These peptide-based drugs are now being explored for a wide range of applications. Explore analytical innovations that ensure safety and efficacy as these peptides expand into multiple treatments.
|
|
|
|
|
Unpack the rapidly evolving landscape of GLP-1 therapeutics—an area gaining momentum for its potential in treating metabolic disorders such as diabetes and obesity—with expert Matt Lauber to gain insight into GLP-1 therapeutics, analytical challenges, and the innovations shaping the future of biopharmaceuticals.
|
|
|
|
|
The role of synthetic peptides in drug development is rapidly expanding, driven by their versatility and ability to target specific biological pathways with high precision. Discover how advanced RP chromatography methods are vital for impurity profiling to ensure safety and efficacy.
|
|
|
|
|
A novel analytical approach utilizing HPLC coupled with UV and mass spectrometry (HPLC-UV/MS) has been developed to enhance the characterization of GLP-1 analogs. Uncover how this method analyzes GLP-1 analogs to address critical challenges in peptide separation, impurity detection, and performance for improved reproducibility.
|
|
|
|
|
|
GLP-1 Receptor Agonist Solutions
|
Waters offers comprehensive workflow solutions that streamline every stage of GLP-1 receptor agonist development—from characterization to purification—helping accelerate the delivery of safe therapies.
|
|
• Request Information
|
|
|
|
|
|
|
|
|
|
|
|
